Skip to main content

Advertisement

Log in

Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson’s disease: a pilot study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Chronic constipation is a highly prevalent and often under-appreciated gastrointestinal disorder in PD associated with significant impairment in quality of life. In this study, we investigated the efficacy and safety of PHGG plus hyaluronate (PHGG+) in patients suffering from PD and constipation. Thirty-four PD patients have been recruited in an open-label pilot study and measured symptoms and quality of life instruments related to constipation. PHGG+ showed to have a minimal still significant effect in improving constipation as measured by PAC Symp and CGI-S. PHGG+ is safe and well tolerated. Data suggests that PHGG+ may be considered efficacious in alleviating symptoms of constipation in PD patients. Trial registration number: NCT04569656/24 Sept. 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaye J, Gage H, Kimber A, Storey L, Trend P (2006) Excess burden of constipation in Parkinson’s disease: a pilot study. Mov Disord 21:1270–1273

    Article  Google Scholar 

  2. Brandt LJ, Schoenfeld P, Prather CM, Schiller LR, Schoenfeld P, Talley NJ (2005) An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 100:S5–S22

  3. Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 14:625–639

    Article  CAS  Google Scholar 

  4. Knudsen K, Krogh K, Ostergaard K, Borghammer P (2017) Constipation in Parkinson’s Disease: subjective symptoms, objective markers, and new prospective. Mov Disord 32(1):94–105

    Article  Google Scholar 

  5. Stocchi F, Badiali D, Vacca L, D’Alba L, Bracci F, Ruggieri S, Torti M, Berardelli A, Corazziari E (2000) Anorectal function in multiple systematrophy and Parkinson’s disease. Mov Disord 15(1):71–76

    Article  CAS  Google Scholar 

  6. Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ et al (2014) Health-related quality of life in early Parkinson’s disease: the impact of non-motor symptoms. Mov Disord 2:195–202

    Article  Google Scholar 

  7. High fibre and guar gum are equally helpful in IBS, but gum is better tolerated (2002) BMJ. Dec 7; 325(7376)

  8. Russo L, Andreozzi P, Zito FP, Vozzella L, Savino IG, Sarnelli G, Cuomo R (2015) Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index. Saudi J Gastroenterol 21(2):104–110

    Article  Google Scholar 

  9. Pedrosa AJ, Carrasco (2018) Management of constipation in patients with Parkinson’s disease. NPJ Parkinson’s Disease 4:6

    Article  Google Scholar 

  10. Braak H, Rüb U, Gai WP, del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517–536

    Article  CAS  Google Scholar 

  11. Hawkes CH, del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599–614

    Article  CAS  Google Scholar 

  12. Hawkes CH, del Tredici K, Braak H (2009) Parkinson’s disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615–622

    Article  Google Scholar 

  13. Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G (2018) Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical review. J Neurogastroenterol Motil 24:30–42

    Article  Google Scholar 

  14. Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30:350–358

    Article  Google Scholar 

  15. Orimo S, Ghebremedhin E, Gelpi E (2018) Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD. Cell Tissue Res 373(1):267–286

    Article  Google Scholar 

Download references

Availability of data and material

The data set is available if required.

Author information

Authors and Affiliations

Authors

Contributions

All the authors contributed to the ideation and conduction of the study. The manuscript has been revised by all the authors who contributed to it.

Corresponding author

Correspondence to Fabrizio Stocchi.

Ethics declarations

Ethical approval

The study was approved by IRCCS San Raffaele IRB.

Conflict of interest

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vacca, L., Proietti, S., Bravi, D. et al. Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson’s disease: a pilot study. Neurol Sci 43, 1055–1059 (2022). https://doi.org/10.1007/s10072-021-05342-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05342-8

Keywords

Navigation